<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="edm" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">edm</book-part-id>
      <title-group>
        <title>Multiple Epiphyseal Dysplasia, Recessive</title>
        <alt-title alt-title-type="alt-title">Synonyms: EDM4, rMED</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bonaf&#x000e9;</surname>
            <given-names>Luisa</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Associate Professor; Head, Division of Molecular Pediatrics<break/>Lausanne University Hospital<break/>Lausanne, Switzerland</aff>
          <email>luisa.bonafe@chuv.ch</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mittaz-Crettol</surname>
            <given-names>Laur&#x000e9;ane</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Laboratory of Molecular Pediatrics<break/>Lausanne University Hospital<break/>Lausanne, Switzerland</aff>
          <email>laureane.mittaz-crettol@chuv.ch</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ballhausen</surname>
            <given-names>Diana</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Senior Lecturer, Division of Molecular Pediatrics<break/>Lausanne University Hospital<break/>Lausanne, Switzerland</aff>
          <email>diana.ballhausen@chuv.ch</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Superti-Furga</surname>
            <given-names>Andrea</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Professor of Pediatrics, Department of Pediatrics<break/>Lausanne University Hospital<break/>Lausanne, Switzerland</aff>
          <email>asuperti@unil.ch</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>29</day>
          <month>8</month>
          <year>2002</year>
        </date>
        <date date-type="updated">
          <day>23</day>
          <month>1</month>
          <year>2014</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="edm-ad" document-type="chapter">Multiple Epiphyseal Dysplasia, Autosomal Dominant</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="myhre" document-type="chapter">Myhre Syndrome</related-object>
      <abstract id="edm.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Recessive multiple epiphyseal dysplasia (EDM4/rMED) is characterized by joint pain (usually in the hips or knees); malformations of hands, feet, and knees; and scoliosis. Approximately 50% of affected individuals have an abnormal finding at birth, e.g., clubfoot, clinodactyly, or (rarely) cystic ear swelling. Onset of articular pain is variable but usually occurs in late childhood. Stature is usually within the normal range prior to puberty; in adulthood, stature is only slightly diminished and ranges from 150 to 180 cm. Functional disability is mild.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Diagnosis of EDM4/rMED is based on clinical and radiographic findings. <italic toggle="yes">SLC26A2</italic> is the only gene in which pathogenic variants are known to cause EDM4/rMED.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Physiotherapy for muscular strengthening and maintaining mobility; cautious use of analgesic medications such as nonsteroidal anti-inflammatory drugs (NSAIDs); orthopedic surgery (joint replacement) as indicated; career counseling.</p>
          <p><italic toggle="yes">Prevention of secondary complications</italic>: Intensive physiotherapy may help in delaying joint contractures and in maintaining mobility.</p>
          <p><italic toggle="yes">Surveillance:</italic> Radiographs as indicated.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Sports involving joint overload.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>EDM4/rMED is inherited in an autosomal recessive manner. At conception, each sib of a proband with EDM4/rMED has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk is possible if both pathogenic alleles in the family are known and the carrier status of the parents has been confirmed. Requests for prenatal testing for mild conditions such as EDM4/rMED are not common.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="edm.Diagnosis">
        <title>Diagnosis</title>
        <sec id="edm.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The diagnosis of recessive multiple epiphyseal dysplasia (EDM4/rMED) is usually established during childhood or early adulthood. The diagnosis is suspected in individuals with the following:</p>
          <p>
            <bold>Clinical features</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Joint pain (usually in the hips and knees). Onset of pain is variable, but usually occurs in late childhood. Some individuals have no pain.</p>
            </list-item>
            <list-item>
              <p>Deformity of hands, feet, and knees</p>
            </list-item>
            <list-item>
              <p>Scoliosis</p>
            </list-item>
          </list>
          <p><bold>Radiographic findings.</bold> Skeletal radiographs establish the diagnosis in clinically suspected individuals (see <xref ref-type="fig" rid="edm.F1">Figure 1</xref>). Typical findings include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Flat epiphyses with early arthritis (degenerative and painful changes in the articular cartilage of the hip joint)</p>
            </list-item>
            <list-item>
              <p>Mild brachydactyly</p>
            </list-item>
            <list-item>
              <p>Double-layered patella (i.e., presence of a separate anterior and posterior ossification layer) observed in approximately 60% of individuals on lateral knee radiographs. This finding appears to be age-related and may disappear in adults (<xref ref-type="fig" rid="edm.F1">Figure 1</xref>).</p>
            </list-item>
          </list>
        </sec>
        <sec id="edm.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Gene.</bold>
<italic toggle="yes">SLC26A2</italic> (<italic toggle="yes">DTDST</italic>) is the only gene in which pathogenic variants are known to cause with EDM4/rMED.</p>
          <p>
            <bold>Clinical testing.</bold>
          </p>
          <table-wrap id="edm.T.summary_of_molecular_genetic_testi" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Multiple Epiphyseal Dysplasia, Recessive</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_edm.T.summary_of_molecular_genetic_testi_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_edm.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_edm.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variants Detected&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_edm.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_edm.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">SLC26A2</italic>
                  </td>
                  <td headers="hd_h_edm.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Targeted analysis for pathogenic variants</td>
                  <td headers="hd_h_edm.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Panel of selected pathogenic variants&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_edm.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">See footnote 5</td>
                </tr>
                <tr>
                  <td headers="hd_h_edm.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_edm.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  <td headers="hd_h_edm.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;90%&#x000a0;<sup>7</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_edm.T.summary_of_molecular_genetic_testi_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>8</sup></td>
                  <td headers="hd_h_edm.T.summary_of_molecular_genetic_testi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">(Multi)exon and whole-gene deletions/duplications</td>
                  <td headers="hd_h_edm.T.summary_of_molecular_genetic_testi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Unknown; none reported</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="edm.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="edm" object-id="edm.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="edm.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="edm.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="edm.TF.1.3">
                <label>3. </label>
                <p>% of disease alleles detected in individuals with typical clinical, radiologic, and histologic features of ACG1B</p>
              </fn>
              <fn id="edm.TF.1.4">
                <label>4. </label>
                <p>Variant panel may vary by laboratory.</p>
              </fn>
              <fn id="edm.TF.1.5">
                <label>5. </label>
                <p>Dependent on variant panel and population tested. The four most common <italic toggle="yes">SLC26A2</italic> pathogenic variants (<xref ref-type="table" rid="edm.T.slc26a2_variants_discussed_in_this">p.Arg279Trp</xref>, <xref ref-type="table" rid="edm.T.slc26a2_variants_discussed_in_this">c.-26+2T&#x0003e;C</xref>, <xref ref-type="table" rid="edm.T.slc26a2_variants_discussed_in_this">p.Arg178Ter</xref>, and <xref ref-type="table" rid="edm.T.slc26a2_variants_discussed_in_this">p.Cys653Ser</xref>) account for approximately 70% of disease alleles in all <italic toggle="yes">SLC26A2</italic>-related dysplasias, but only 10% of disease alleles in ACG1B.</p>
              </fn>
              <fn id="edm.TF.1.6">
                <label>6. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected.For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="edm.TF.1.7">
                <label>7. </label>
                <p>90% of alleles in individuals with radiologic and histologic features compatible with the diagnosis of sulfate transporter-related dysplasias [<xref ref-type="bibr" rid="edm.REF.rossi.2001.159">Rossi &#x00026; Superti-Furga 2001</xref>].</p>
              </fn>
              <fn id="edm.TF.1.8">
                <label>8. </label>
                <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="edm.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis in a proband.</bold> Clinical and radiologic features may strongly suggest the diagnosis of EDM4/rMED in a proband.</p>
          <p>The presence of a double-layered patella at lateral x-ray of the knee is a very specific, although not highly sensitive, sign of EDM4/rMED [<xref ref-type="bibr" rid="edm.REF.m_kitie.2003.187">M&#x000e4;kitie et al 2003</xref>].</p>
          <p><bold>Targeted analysis for the four most common <italic toggle="yes">SLC26A2</italic> pathogenic variants is indicated</bold> in probands with clinical and radiologic features very suggestive for EDM4/rMED and/or with a clinical diagnosis of MED and no evidence of autosomal dominant inheritance. This test allows identification of at least one pathogenic allele in nearly 100% of EDM4/rMED cases (80% of individuals with EDM4/rMED carry two of the most common pathogenic variants, and another 16% of cases carry one of the most common pathogenic variants in compound heterozygosity with another pathogenic allele).</p>
          <p><bold>Sequence analysis of <italic toggle="yes">SLC26A2</italic> is indicated</bold> in probands with only one heterozygous <italic toggle="yes">SLC26A2</italic> pathogenic variant and in probands who tested negative with targeted analysis for pathogenic variants and have very specific signs of EDM4/rMED (double-layered patella and/or classic signs of sulfate transporter-related dysplasia, like clubfoot, cleft palate, and cystic swelling of the ears).</p>
          <p><bold>Sequence analysis of <italic toggle="yes">SLC26A2</italic> may be considered</bold> in simplex cases (i.e., a single occurrence in a family) with no specific signs for a distinct autosomal dominant MED type before testing other known MED-related genes, as recessive pathogenic variants in <italic toggle="yes">SLC26A2</italic> are found more frequently in simplex cases than dominant pathogenic variants in other MED-related genes [<xref ref-type="bibr" rid="edm.REF.jakkula.2005.292">Jakkula et al 2005</xref>].</p>
          <p><bold>Single-gene testing.</bold> One strategy for molecular diagnosis of a proband suspected of having EDM4/rMED is sequence analysis of only <italic toggle="yes">SLC26A2</italic>.</p>
          <p><bold>Multi-gene panel.</bold> Another strategy for molecular diagnosis of a proband suspected of having EDM4/rMED is use of a multi-gene panel (see <xref ref-type="sec" rid="edm.Differential_Diagnosis">Differential Diagnosis</xref>). For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
          <p><bold>Carrier testing for at-risk relatives</bold> requires prior identification of the pathogenic variants in the family.</p>
          <p>Note: Carriers are heterozygotes for this autosomal recessive disorder and are not at risk of developing the disorder.</p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variants in the family.</p>
        </sec>
      </sec>
      <sec id="edm.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="edm.Clinical_Description">
          <title>Clinical Description</title>
          <p>In retrospect, approximately 50% of individuals with recessive multiple epiphyseal dysplasia (EDM4/rMED) have an abnormal finding at birth, such as clubfoot (frequently), clinodactyly, or cleft palate. However, only half of those with findings at birth are suspected of having a skeletal dysplasia.</p>
          <p>The majority of affected individuals are diagnosed with a skeletal disorder in childhood, but some are not diagnosed until adulthood. Reasons for seeking medical assistance are mainly chronic joint pain (hips, knees, wrists, and fingers), waddling gait, hand/foot deformities (mild brachydactyly, clinodactyly, clubfoot, broadening of the space between the first and second toes), and mild scoliosis.</p>
          <p>There is no specific timing of joint involvement or specific location of joint pain at different ages. Adolescents are usually symptomatic in multiple joints and joint pain increases after physical exercise. Brachydactyly is evident after puberty in most cases.</p>
          <p>Habitus is unremarkable in most affected individuals, except for genu valgum in some.</p>
          <p>Facies and body proportions are usually normal. Bowing of the extremities is not observed.</p>
          <p>Functional disability is mild or absent [<xref ref-type="bibr" rid="edm.REF.ballhausen.2003.65">Ballhausen et al 2003</xref>] in childhood and adolescence; joint involvement progresses slightly in young adults, but hip and knee surgery is usually not needed.</p>
          <p>Stature is usually within the normal range prior to puberty and downward crossing of the growth curve does not occur. In adulthood, stature is only slightly diminished, with the median height shifting from the 50th to the tenth centile; range of adult height is 150-180 cm. Approximately one third of affected adults have stature below 2 SD for age.</p>
        </sec>
        <sec id="edm.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Genotype-phenotype correlations indicate that the amount of residual activity of the sulfate transporter modulates the phenotype in a spectrum that goes from lethal <related-object link-type="booklink" source-id="gene" document-id="achon1b" document-type="chapter">achondrogenesis 1B</related-object> (ACG1B) to mild EDM4/rMED.</p>
          <list list-type="bullet">
            <list-item>
              <p>Homozygosity or compound heterozygosity for pathogenic variants predicting stop codons or structural pathogenic variants in transmembrane domains of the sulfate transporter are associated with ACG1B.</p>
            </list-item>
            <list-item>
              <p>Pathogenic variants located in extracellular loops, in the cytoplasmic tail of the protein, or in the regulatory 5'-flanking region of the gene result in less severe phenotypes [<xref ref-type="bibr" rid="edm.REF.supertifurga.1996a.195">Superti-Furga et al 1996a</xref>, <xref ref-type="bibr" rid="edm.REF.karniski.2001.1485">Karniski 2001</xref>, <xref ref-type="bibr" rid="edm.REF.rossi.2001.159">Rossi &#x00026; Superti-Furga 2001</xref>, <xref ref-type="bibr" rid="edm.REF.karniski.2004.2165">Karniski 2004</xref>].</p>
            </list-item>
          </list>
          <p>Variant <xref ref-type="table" rid="edm.T.slc26a2_variants_discussed_in_this">p.Arg279Trp</xref>, the most common <italic toggle="yes">SLC26A2</italic> pathogenic variant outside Finland (45% of alleles) is a mild pathogenic variant resulting in the EDM4/rMED phenotype when homozygous and mostly in the <related-object link-type="booklink" source-id="gene" document-id="diastrophic-d" document-type="chapter">diastrophic dysplasia</related-object> (DTD) phenotype when compounded.</p>
          <p>Variant <xref ref-type="table" rid="edm.T.slc26a2_variants_discussed_in_this">p.Arg178Ter</xref> is the second-most common pathogenic variant (9% of alleles) and is associated with a more severe DTD phenotype or even the perinatal-lethal AO2 phenotype, particularly when combined <italic toggle="yes">in</italic>
<italic toggle="yes">trans</italic> with the p.Arg279Trp pathogenic variant. It has also been found in some cases of more severe rMED and of ACG1B, making it one of two pathogenic variants identified in all four <italic toggle="yes">SLC26A2</italic>-related dysplasias.</p>
          <p>Variants p.Cys653Ser and c.-26+2T&#x0003e;C are the third most common pathogenic variants (8% of alleles for each).</p>
          <p><xref ref-type="table" rid="edm.T.slc26a2_variants_discussed_in_this">c.-26+2T&#x0003e;C</xref> is sometimes referred to as the "Finnish" pathogenic variant because it is much more frequent in Finland than in the remainder of the world population. It produces low levels of correctly spliced mRNA and results in DTD when homozygous and in rMED when compounded with another mild pathogenic variant (<xref ref-type="table" rid="edm.T.slc26a2_variants_discussed_in_this">p.Arg279Trp</xref>, <xref ref-type="table" rid="edm.T.slc26a2_variants_discussed_in_this">p.Cys653Ser</xref>).</p>
          <p>Together with p.Arg178Ter, <xref ref-type="table" rid="edm.T.slc26a2_variants_discussed_in_this">c.-26+2T&#x0003e;C</xref> is the only pathogenic variant that has been identified in all four <italic toggle="yes">SLC26A2</italic>-related dysplasias, in compound heterozygosity with mild (rMED and DTD) or severe (AO2 and ACG1B) alleles [<xref ref-type="bibr" rid="edm.REF.dwyer.2010.3043">Dwyer et al 2010</xref>; Bonaf&#x000e9;, unpublished results].</p>
          <p>Pathogenic variant <xref ref-type="table" rid="edm.T.slc26a2_variants_discussed_in_this">p.Cys653Ser</xref> results in EDM4/rMED when homozygous and in EDM4/rMED or DTD when compounded with other pathogenic variants.</p>
          <p>The same pathogenic variants associated in some individuals with the ACG1B phenotype can be found in individuals with a milder phenotype (AO2 and DTD) if the second allele is a relatively mild pathogenic variant. Indeed, missense variants located outside the transmembrane domain of the sulfate transporter are often associated with a residual activity that can "rescue" the effect of the null allele [<xref ref-type="bibr" rid="edm.REF.rossi.2001.159">Rossi &#x00026; Superti-Furga 2001</xref>].</p>
        </sec>
        <sec id="edm.Nomenclature">
          <title>Nomenclature</title>
          <p>Multiple epiphyseal dysplasia is a disorder with clinical and genetic heterogeneity. In the past, the disorder was clinically subdivided into the milder Ribbing type, with flattened epiphysis and normal or near-normal stature; the more severe Fairbank type, with round, small epiphyses and short stature; and the unclassified types [<xref ref-type="bibr" rid="edm.REF.international_working_group_on_constitutional_diseases_of_bone.1998.376">International Working Group on Constitutional Diseases of Bone 1998</xref>].</p>
          <p>The genetic dissection of this heterogeneous group of conditions in recent years has provided a molecular-pathogenic classification of the different subtypes according to the gene involved:</p>
          <list list-type="bullet">
            <list-item>
              <p>EDM4/rMED is classified in the "sulfation disorders group" in the revised Nosology and Classification of Genetic Skeletal Disorders of Bone [<xref ref-type="bibr" rid="edm.REF.warman.2011.943">Warman et al 2011</xref>]. It accounts for about 25% of cases of MED.</p>
            </list-item>
            <list-item>
              <p>The other autosomal dominant subtypes of MED are classified in the "multiple epiphyseal dysplasia and pseudoachondroplasia group" in the revised Nosology. The most frequent form of MED is caused by dominant pathogenic variants in <italic toggle="yes">COMP</italic> (~50% of cases). The remaining 20%-25% of cases are split between <italic toggle="yes">MATN3, COL9A1, COL9A2</italic>, and <italic toggle="yes">COL9A3</italic>.</p>
            </list-item>
            <list-item>
              <p>Some cases of MED are not caused by pathogenic variants in a known gene [<xref ref-type="bibr" rid="edm.REF.zankl.2007.150">Zankl et al 2007</xref>, <xref ref-type="bibr" rid="edm.REF.unger.2008.19">Unger et al 2008</xref>] and remain unclassified.</p>
            </list-item>
          </list>
        </sec>
        <sec id="edm.Prevalence">
          <title>Prevalence</title>
          <p>Exact data about the prevalence of MED and its subtypes are not available. Based on the number of cases seen in growth clinics, rheumatology clinics, or genetics clinics, and compared to conditions whose incidences are more precisely known (e.g., <related-object link-type="booklink" source-id="gene" document-id="achondroplasia" document-type="chapter">achondroplasia</related-object>, <related-object link-type="booklink" source-id="gene" document-id="oi" document-type="chapter">osteogenesis imperfecta</related-object>), it seems reasonable to estimate an overall prevalence of 1:20,000 [<xref ref-type="bibr" rid="edm.REF.unger.2008.19">Unger et al 2008</xref>]. This prevalence is most probably an underestimation as several simplex cases (i.e., a single occurrence in a family) may remain undiagnosed. EDM4/rMED is indeed one of the most frequent forms, accounting for almost 25% of all cases of MED [<xref ref-type="bibr" rid="edm.REF.jackson.2012.144">Jackson et al 2012</xref>].</p>
        </sec>
      </sec>
      <sec id="edm.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Three other skeletal dysplasias (all with an autosomal recessive mode of inheritance) are associated with pathogenic variants in <italic toggle="yes">SLC26A2</italic>:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="achon1b" document-type="chapter"><bold>Achondrogenesis Type 1B</bold></related-object>
<bold>(ACG1B)</bold> is among the most severe skeletal disorders in humans. It is characterized by severe hypodysplasia of the spine, rib cage, and extremities, with a relatively preserved cranium. ACG1B is invariably lethal in the perinatal period [<xref ref-type="bibr" rid="edm.REF.supertifurga.1996b.100">Superti-Furga et al 1996b</xref>].</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="ao2" document-type="chapter"><bold>Atelosteogenesis 2</bold></related-object>
<bold>(AO2)</bold> is a neonatal-lethal chondrodysplasia with clinical and histologic characteristics that resemble those of diastrophic dysplasia [<xref ref-type="bibr" rid="edm.REF.h_stbacka.1996.255">H&#x000e4;stbacka et al 1996</xref>].</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="diastrophic-d" document-type="chapter"><bold>Diastrophic dysplasia</bold></related-object>
<bold>(DTD)</bold> is characterized by short stature, joint contractures, cleft palate, and characteristic clinical signs such as the "hitchhiker" thumb and cystic swelling of external ears.</p>
          </list-item>
        </list>
      </sec>
      <sec id="edm.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Recessive multiple epiphyseal dysplasia (EDM4/rMED) needs to be distinguished from other multiple epiphyseal dysplasia (MED) types [<xref ref-type="bibr" rid="edm.REF.unger.2001.244">Unger &#x00026; Hecht 2001</xref>, <xref ref-type="bibr" rid="edm.REF.ballhausen.2003.65">Ballhausen et al 2003</xref>]. Clinical and radiographic differences between the genetically distinct forms of these skeletal dysplasias may allow clinicians to distinguish between them. In contrast to other MED types, prepubertal children with EDM4/rMED usually do not show short stature.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="edm-ad" document-type="chapter">Autosomal dominant forms of MED</related-object> and their associated proteins and genes:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Cartilage oligomeric matrix protein,</bold> a glycoprotein of the cartilage extracellular matrix that belongs to the family of extracellular calcium-binding proteins. Pathogenic variants in <italic toggle="yes">COMP</italic> occur in different autosomal dominant forms of MED (<bold>EDM1</bold>, OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/132400">132400</ext-link>) as well as in the more severe disorder, <related-object link-type="booklink" source-id="gene" document-id="psach" document-type="chapter">pseudoachondroplasia</related-object>. Individuals with MED and <italic toggle="yes">COMP</italic> pathogenic variants usually have significant involvement at the capital femoral epiphyses and irregular acetabuli [<xref ref-type="bibr" rid="edm.REF.unger.2001.10">Unger et al 2001</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>Type IX collagen,</bold> a structural component of the extracellular matrix, is a heterotrimer composed of three different chains (alpha-1, alpha-2, and alpha-3) encoded by <italic toggle="yes">COL9A1</italic>, <italic toggle="yes">COL9A2</italic>, and <italic toggle="yes">COL9A3</italic>. Pathogenic variants in individuals with MED have been identified in <italic toggle="yes">COL9A2</italic> (<bold>EDM2</bold>) [<xref ref-type="bibr" rid="edm.REF.muragaki.1996.103">Muragaki et al 1996</xref>, <xref ref-type="bibr" rid="edm.REF.holden.1999.31">Holden et al 1999</xref>], <italic toggle="yes">COL9A3</italic> (<bold>EDM3</bold>) [<xref ref-type="bibr" rid="edm.REF.paassilta.1999.1036">Paassilta et al 1999</xref>], and <italic toggle="yes">COL9A1</italic> [<xref ref-type="bibr" rid="edm.REF.czarnyratajczak.2001.969">Czarny-Ratajczak et al 2001</xref>]. These forms of MED appear to have more severe knee involvement but relative sparing of the hip, resulting in a milder course than the MED associated with <italic toggle="yes">COMP</italic> or <italic toggle="yes">SLC26A2</italic> pathogenic variants [<xref ref-type="bibr" rid="edm.REF.unger.2001.10">Unger et al 2001</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>Matrilin 3 (EDM5),</bold> an oligomeric protein in the cartilage extracellular matrix. Different pathogenic missense variants in <italic toggle="yes">MATN3</italic> were identified in two unrelated families with autosomal dominant MED [<xref ref-type="bibr" rid="edm.REF.chapman.2001.393">Chapman et al 2001</xref>]. While it appears to be the mildest form of MED identified to date; EDM5 is associated with a high degree of intrafamilial variability [<xref ref-type="bibr" rid="edm.REF.m_kitie.2004.278">M&#x000e4;kitie et al 2004</xref>, <xref ref-type="bibr" rid="edm.REF.zankl.2007.150">Zankl et al 2007</xref>, <xref ref-type="bibr" rid="edm.REF.unger.2008.19">Unger et al 2008</xref>].</p>
          </list-item>
        </list>
        <p>See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/phenotypicSeries/PS132400">Epiphyseal dysplasia, multiple: OMIM Phenotypic Series</ext-link> to view genes associated with this phenotype in OMIM.</p>
      </sec>
      <sec id="edm.Management">
        <title>Management</title>
        <sec id="edm.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with recessive multiple epiphyseal dysplasia (EDM4/rMED), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Height measurement</p>
            </list-item>
            <list-item>
              <p>Radiographs of the entire spine (AP and lateral), pelvis (AP), and knees (AP and lateral)</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="edm.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Symptomatic individuals should be seen by a physical therapist and an orthopedist in order to assess the possibility of treatment (physiotherapy for muscular strengthening and maintaining mobility, cautious use of analgesic medications such as nonsteroidal anti-inflammatory drugs [NSAIDs]) and the optimal time for surgery (joint replacement), if indicated.</p>
          <p>Career counseling is recommended.</p>
        </sec>
        <sec id="edm.Prevention_of_Secondary_Complication">
          <title>Prevention of Secondary Complications</title>
          <p>Intensive physiotherapy may help in delaying joint contractures and in maintaining mobility.</p>
        </sec>
        <sec id="edm.Surveillance">
          <title>Surveillance</title>
          <p>Radiographic surveillance by an orthopedist is appropriate.</p>
        </sec>
        <sec id="edm.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Sports involving joint overload are to be avoided.</p>
        </sec>
        <sec id="edm.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Presymptomatic testing of at-risk relatives is not indicated because no preventive measures or therapeutic interventions to reduce morbidity are available</p>
          <p>See <xref ref-type="sec" rid="edm.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="edm.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Women affected by EDM4/rMED may suffer from chronic joint pain which may be increased during pregnancy due to maternal weight gain. Appropriate pain management should be offered and physical therapy should be intensified.</p>
        </sec>
        <sec id="edm.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="edm.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="edm.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Recessive multiple epiphyseal dysplasia (EDM4/rMED) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="edm.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected individual are obligate heterozygotes and therefore carry a single copy of a pathogenic variant in <italic toggle="yes">SLC26A2</italic>. Note: Parental testing is always recommended when pathogenic variants are identified in a proband, in order to confirm the segregation of pathogenic variants in the family and confirm the carrier status of both parents. Results should always be discussed with the family in the context of a genetic counseling consultation.</p>
            </list-item>
            <list-item>
              <p>Heterozygous carriers are asymptomatic and have normal stature.</p>
            </list-item>
            <list-item>
              <p>No evidence that carriers are at increased risk of developing degenerative joint disease has been presented.</p>
            </list-item>
            <list-item>
              <p>To date, <italic toggle="yes">de novo</italic> pathogenic variants in a proband and germline mosaicism in the parents have not been reported.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of a proband with EDM4/rMED has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Once an at-risk sib is known to be unaffected, the risk of his/her being a carrier is 2/3.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with EDM4/rMED are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">SLC26A2</italic>.</p>
          <p><bold>Other family members of a proband.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier.</p>
        </sec>
        <sec id="edm.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing for at-risk family members is available on a clinical basis once the pathogenic variants have been identified in the family.</p>
          <p>Carrier detection in reproductive partners of heterozygous individuals is available on a clinical basis. The partners can be screened for the four most common pathogenic alleles: <xref ref-type="table" rid="edm.T.slc26a2_variants_discussed_in_this">p.Arg279Trp</xref>, <xref ref-type="table" rid="edm.T.slc26a2_variants_discussed_in_this">p.Arg178Ter</xref>, <xref ref-type="table" rid="edm.T.slc26a2_variants_discussed_in_this">c.-26+2T&#x0003e;C</xref>, and <xref ref-type="table" rid="edm.T.slc26a2_variants_discussed_in_this">p.Cys653Ser</xref>. The risk of carrying a <italic toggle="yes">SLC26A2</italic> pathogenic variant is reduced from the general population risk of 1:100 to approximately 1:400 when these four alleles are excluded. If a reproductive partner of a carrier also has an <italic toggle="yes">SLC26A2</italic> pathogenic variant, information about genotype-phenotype correlations should be provided to the couple.</p>
        </sec>
        <sec id="edm.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="edm.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p><bold>Molecular genetic testing.</bold> Once the pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for EDM4/eMED are possible.</p>
          <p><bold>Biochemical testing.</bold> No data exist on prenatal functional biochemical testing (sulfate incorporation test on chorionic villus or fibroblasts).</p>
          <p>Requests for prenatal testing for conditions which (like EDM4/rMED) are mild and do not affect intellect are not common. Differences in perspective may exist among medical professionals and in families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="edm.Resources">
        <title>Resources</title>
      </sec>
      <sec id="edm.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="edm.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Pathogenic variants in <italic toggle="yes">SLC26A2</italic> (<italic toggle="yes">DTDST</italic>) are responsible for the family of chondrodysplasias including EDM4/rMED, <related-object link-type="booklink" source-id="gene" document-id="diastrophic-d" document-type="chapter">DTD</related-object>, <related-object link-type="booklink" source-id="gene" document-id="achon1b" document-type="chapter">ACG1B</related-object>, and <related-object link-type="booklink" source-id="gene" document-id="ao2" document-type="chapter">AO2</related-object> [<xref ref-type="bibr" rid="edm.REF.h_stbacka.1996.255">H&#x000e4;stbacka et al 1996</xref>, <xref ref-type="bibr" rid="edm.REF.supertifurga.1996a.195">Superti-Furga et al 1996a</xref>, <xref ref-type="bibr" rid="edm.REF.supertifurga.1999.621">Superti-Furga et al 1999</xref>]. Impaired activity of the sulfate transporter in chondrocytes and fibroblasts results in the synthesis of proteoglycans that are not sulfated or are insufficiently sulfated [<xref ref-type="bibr" rid="edm.REF.supertifurga.1994.1137">Superti-Furga 1994</xref>, <xref ref-type="bibr" rid="edm.REF.rossi.1997.741">Rossi et al 1997</xref>, <xref ref-type="bibr" rid="edm.REF.rossi.1998.361">Rossi et al 1998</xref>, <xref ref-type="bibr" rid="edm.REF.satoh.1998.12307">Satoh et al 1998</xref>], most probably because of intracellular sulfate depletion [<xref ref-type="bibr" rid="edm.REF.rossi.1996.18456">Rossi et al 1996</xref>]. Undersulfation of proteoglycans affects the composition of the extracellular matrix and leads to impairment of proteoglycan deposition, which is necessary for proper enchondral bone formation [<xref ref-type="bibr" rid="edm.REF.corsi.2001.1375">Corsi et al 2001</xref>]. A correlation exists between the pathogenic variant, the predicted residual activity of the sulfate transporter, and the predicted severity of the phenotype [<xref ref-type="bibr" rid="edm.REF.cai.1998.58">Cai et al 1998</xref>, <xref ref-type="bibr" rid="edm.REF.rossi.2001.159">Rossi &#x00026; Superti-Furga 2001</xref>, <xref ref-type="bibr" rid="edm.REF.karniski.2004.2165">Karniski 2004</xref>].</p>
          <p><bold>Gene structure.</bold> The coding sequence of <italic toggle="yes">SLC26A2</italic> is organized in two coding exons separated by an intron of approximately 1.8 kb [<xref ref-type="bibr" rid="edm.REF.h_stbacka.1994.1073">H&#x000e4;stbacka et al 1994</xref>]. A further untranslated exon is located 5' relative to the two coding exons; it probably has regulatory functions, [<xref ref-type="bibr" rid="edm.REF.h_stbacka.1999.664">H&#x000e4;stbacka et al 1999</xref>]. <italic toggle="yes">SLC26A2</italic> is expressed in developing cartilage in human fetuses but also in a wide variety of other tissues [<xref ref-type="bibr" rid="edm.REF.haila.2001.973">Haila et al 2001</xref>]. The size of the predominant mRNA species is greater than 8 kb, indicating the existence of significant untranslated sequences [<xref ref-type="bibr" rid="edm.REF.h_stbacka.1994.1073">H&#x000e4;stbacka et al 1994</xref>, <xref ref-type="bibr" rid="edm.REF.h_stbacka.1999.664">H&#x000e4;stbacka et al 1999</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="edm" object-id="edm.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Benign variants.</bold> The p.Thr689Ser allele has been frequently observed in the heterozygous or homozygous state in several controls of different ethnicity and is thus a common benign variant [<xref ref-type="bibr" rid="edm.REF.cai.1998.58">Cai et al 1998</xref>, <xref ref-type="bibr" rid="edm.REF.rossi.2001.159">Rossi &#x00026; Superti-Furga 2001</xref>].</p>
          <p>There is evidence that p.Arg492Trp is a rare benign variant found in seven out of 200 Finnish control individuals and in five out of 150 non-Finnish individuals [<xref ref-type="bibr" rid="edm.REF.bonaf_.2008.827">Bonaf&#x000e9; et al 2008</xref>]. This allele may have been erroneously considered pathogenic in previous reports [<xref ref-type="bibr" rid="edm.REF.rossi.2001.159">Rossi &#x00026; Superti-Furga 2001</xref>].</p>
          <p><bold>Pathogenic variants.</bold> Four pathogenic alleles of <italic toggle="yes">SLC26A2</italic> appear to be recurrent: p.Arg279Trp, p.Arg178Ter, c.-26+2T&#x0003e;C, and p.Cys653Ser. Together they represent approximately 70% of the pathogenic variants in <italic toggle="yes">SLC26A2.</italic></p>
          <p>Most pathogenic variants associated with EDM4/rMED are amino acid substitutions outside transmembrane domains of the sulfate transporter. The p.Arg279Trp variant is the most common pathogenic variant in persons of northern European origin. When homozygous, it results in an EDM4/rMED phenotype; when heterozygous, the phenotype depends on the severity of the pathogenic variant of the second allele (if compounded with a mild pathogenic variant it results in EDM4/rMED, while if compounded with a truncated allele or an amino acid substitution in a transmembrane domain, it results in DTD). Apart from homozygosity for p.[Arg279Trp]+[Arg279Trp] (55% of all EDM4/rMED cases) or for p.[Cys653Ser]+[Cys653Ser] (10%), compound heterozygosity for c.[835C&#x0003e;T] + [-26+2T&#x0003e;C] (10%) and c.[1957T&#x0003e;A ] +[-26+2T&#x0003e;C] (5%) is also common in EDM4/rMED. Other compound heterozygous combinations are also found in EDM4/rMED, most of which include one of the four most common <italic toggle="yes">SLC26A2</italic> pathogenic variants (&#x0003e;95% of all individuals with molecularly confirmed EDM4/rMED have at least one of the 4 common <italic toggle="yes">SLC26A2</italic> pathogenic variants). There are a few other recurrent pathogenic variants in individuals with EDM4/rMED, including p.Phe256Ser and p.Phe595Leu (neither of which is found in other <italic toggle="yes">SLC26A2</italic>-related dysplasias).</p>
          <p>Distinct phenotypes known to be allelic to EDM4/rMED are diastrophic dysplasia (DTD), atelosteogenesis type 2 (AO2), and achondrogenesis 1B (ACG1B).</p>
          <table-wrap id="edm.T.slc26a2_variants_discussed_in_this" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p><italic toggle="yes">SLC26A2</italic> Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Classification</th>
                  <th id="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                  <th id="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Benign</bold>
                  </td>
                  <td headers="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.1474C&#x0003e;T</td>
                  <td headers="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg492Trp</td>
                  <td headers="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_4" rowspan="8" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/100913029">NM_000112.3</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/100913030">NP_000103.2</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2065A&#x0003e;T</td>
                  <td headers="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Thr689Ser</td>
                </tr>
                <tr>
                  <td headers="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_1" rowspan="6" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Pathogenic</bold>
                  </td>
                  <td headers="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.-26+2T&#x0003e;C<break/>(IVS1+2T&#x0003e;C)</td>
                  <td headers="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                </tr>
                <tr>
                  <td headers="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.532C&#x0003e;T</td>
                  <td headers="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg178Ter</td>
                </tr>
                <tr>
                  <td headers="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.767T&#x0003e;C</td>
                  <td headers="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Phe256Ser</td>
                </tr>
                <tr>
                  <td headers="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.835C&#x0003e;T</td>
                  <td headers="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg279Trp</td>
                </tr>
                <tr>
                  <td headers="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1783T&#x0003e;C</td>
                  <td headers="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Phe595Leu</td>
                </tr>
                <tr>
                  <td headers="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.1957T&#x0003e;A</td>
                  <td headers="hd_h_edm.T.slc26a2_variants_discussed_in_this_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Cys653Ser</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors.&#x000a0;<italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic>&#x000a0;follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="edm.TF.2.1">
                <label>1. </label>
                <p>Variant designation that does not conform to current naming conventions</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold>
<italic toggle="yes">SLC26A2</italic> encodes a sulfate transporter protein of 739 amino acids that is predicted to have 12 transmembrane domains and a carboxy-terminal, cytoplasmic, moderately hydrophobic domain [<xref ref-type="bibr" rid="edm.REF.h_stbacka.1994.1073">H&#x000e4;stbacka et al 1994</xref>]. This protein transports sulfate into chondrocytes to maintain adequate sulfation of proteoglycans. The sulfate transporter protein belongs to the family of sulfate permeases. The overall structure with 12 membrane-spanning domains is shared with two other human anion exchangers: PDS (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/274600">274600</ext-link>), a chloride-iodide transporter involved in <related-object link-type="booklink" source-id="gene" document-id="pendred" document-type="chapter">Pendred syndrome</related-object>, and CLD, which is responsible for congenital chloride diarrhea. The function of the carboxy-terminal hydrophobic domain of the sulfate transporter is not yet known.</p>
          <p><bold>Abnormal gene product.</bold> Most of the <italic toggle="yes">SLC26A2</italic> pathogenic variants either predict a truncated polypeptide chain or affect amino acids that are located in transmembrane domains or are conserved in man, mouse, and rat. Individuals homozygous for the "Finnish" pathogenic variant c.-26+2T&#x0003e;C have reduced levels of mRNA with intact coding sequence. Thus, the variant presumably interferes with splicing and/or further mRNA processing and transport [<xref ref-type="bibr" rid="edm.REF.h_stbacka.1996.255">H&#x000e4;stbacka et al 1996</xref>, <xref ref-type="bibr" rid="edm.REF.h_stbacka.1999.664">H&#x000e4;stbacka et al 1999</xref>].</p>
          <p>The p.Arg178Ter pathogenic variant was shown to abolish sulfate transporter activity in a <italic toggle="yes">Xenopus</italic> oocyte model [<xref ref-type="bibr" rid="edm.REF.karniski.2001.1485">Karniski 2001</xref>].</p>
        </sec>
      </sec>
      <sec id="edm.References">
        <title>References</title>
        <sec id="edm.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="edm.Literature_Cited.reflist0">
            <ref id="edm.REF.ballhausen.2003.65">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ballhausen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaf&#x000e9;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terhal</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Unger</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellus</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Classen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spranger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohn</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hecht</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Recessive multiple epiphyseal dysplasia (rMED): phenotype delineation in eighteen homozygotes for DTDST mutation R279W.</article-title>
                <source>J Med Genet</source>
                <volume>40</volume>
                <fpage>65</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">12525546</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.bonaf_.2008.827">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bonaf&#x000e9;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000e4;stbacka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Chapelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campos-Xavier</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiesa</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forlino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>A novel mutation in the sulfate transporter gene SLC26A2 (DTDST) specific to the Finnish population causes de la Chapelle dysplasia.</article-title>
                <source>J Med Genet</source>
                <volume>45</volume>
                <fpage>827</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">18708426</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.cai.1998.58">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cai</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakayama</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiraki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozono</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Mutational analysis of the DTDST gene in a fetus with achondrogenesis type 1B.</article-title>
                <source>Am J Med Genet</source>
                <volume>78</volume>
                <fpage>58</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">9637425</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.chapman.2001.393">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loughlin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grant</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briggs</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia.</article-title>
                <source>Nat Genet</source>
                <volume>28</volume>
                <fpage>393</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11479597</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.corsi.2001.1375">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Corsi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riminucci</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>LW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bianco</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Achondrogenesis type IB: agenesis of cartilage interterritorial matrix as the link between gene defect and pathological skeletal phenotype.</article-title>
                <source>Arch Pathol Lab Med</source>
                <volume>125</volume>
                <fpage>1375</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11570921</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.czarnyratajczak.2001.969">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Czarny-Ratajczak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohiniva</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogala</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozlowski</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perala</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spector</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolodziej</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seppanen</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glazar</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krolewski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latos-Bielenska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ala-Kokko</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity.</article-title>
                <source>Am J Hum Genet</source>
                <volume>69</volume>
                <fpage>969</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">11565064</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.dwyer.2010.3043">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dwyer</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hyland</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Modaff</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pauli</surname>
                    <given-names>RM</given-names>
                  </name>
                </person-group>
                <article-title>Genotype-phenotype correlation in DTDST dysplasias: Atelosteogenesis type II and diastrophic dysplasia variant in one family.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2010</year>
                <volume>152A</volume>
                <fpage>3043</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">21077202</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.haila.2001.973">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haila</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000e4;stbacka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohling</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karjalainen-Lindsberg</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kere</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saarialho-Kere</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>SLC26A2 (diastrophic dysplasia sulfate transporter) is expressed in developing and mature cartilage but also in other tissues and cell types.</article-title>
                <source>J Histochem Cytochem</source>
                <volume>49</volume>
                <fpage>973</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">11457925</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.h_stbacka.1994.1073">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>H&#x000e4;stbacka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Chapelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahtani</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clines</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reeve-Daly</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daly</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamilton</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kusumi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trivedi</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weaver</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coloma</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lovett</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buckler</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaitila</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lander</surname>
                    <given-names>ES</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>The diastrophic dysplasia gene encodes a novel sulfate transporter: positional cloning by fine-structure linkage disequilibrium mapping.</article-title>
                <source>Cell</source>
                <volume>78</volume>
                <fpage>1073</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">7923357</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.h_stbacka.1999.664">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>H&#x000e4;stbacka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerrebrock</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mokkala</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clines</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lovett</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaitila</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Chapelle</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lander</surname>
                    <given-names>ES</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Identification of the Finnish founder mutation for diastrophic dysplasia (DTD).</article-title>
                <source>Eur J Hum Genet</source>
                <volume>7</volume>
                <fpage>664</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">10482955</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.h_stbacka.1996.255">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>H&#x000e4;stbacka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcox</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimoin</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohn</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lander</surname>
                    <given-names>ES</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias.</article-title>
                <source>Am J Hum Genet</source>
                <volume>58</volume>
                <fpage>255</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">8571951</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.holden.1999.31">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holden</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canty</surname>
                    <given-names>EG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spranger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carr</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grant</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loughlin</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briggs</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Identification of novel pro-alpha2(IX) collagen gene mutations in two families with distinctive oligo-epiphyseal forms of multiple epiphyseal dysplasia.</article-title>
                <source>Am J Hum Genet</source>
                <volume>65</volume>
                <fpage>31</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10364514</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.international_working_group_on_constitutional_diseases_of_bone.1998.376">
              <element-citation publication-type="journal">
                <person-group>
                  <collab>International Working Group on Constitutional Diseases of Bone</collab>
                </person-group>
                <year>1998</year>
                <article-title>International nomenclature and classification of the osteochondrodysplasias, 1997.</article-title>
                <source>Am J Med Genet</source>
                <volume>79</volume>
                <fpage>376</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">9779805</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.jackson.2012.144">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mittaz-Crettol</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spranger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Offiah</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wright</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savarirayan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishimura</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramsden</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elles</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaf&#x000e9;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Unger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zankl</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briggs</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Pseudoachondroplasia and multiple epiphyseal dysplasia: a 7-year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contribution.</article-title>
                <source>Hum Mutat.</source>
                <volume>33</volume>
                <fpage>144</fpage>
                <lpage>57</lpage>
                <pub-id pub-id-type="pmid">21922596</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.jakkula.2005.292">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jakkula</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e4;kitie</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Czarny-Ratajczak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damignani</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Susic</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briggs</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ala-Kokko</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Mutations in the known genes are not the major cause of MED; distinctive phenotypic entities among patients with no identified mutations.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>13</volume>
                <fpage>292</fpage>
                <lpage>301</lpage>
                <pub-id pub-id-type="pmid">15523498</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.karniski.2001.1485">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Karniski</surname>
                    <given-names>LP</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene: correlation between sulfate transport activity and chondrodysplasia phenotype.</article-title>
                <source>Hum Mol Genet</source>
                <volume>10</volume>
                <fpage>1485</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">11448940</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.karniski.2004.2165">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Karniski</surname>
                    <given-names>LP</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Functional expression and cellular distribution of diastrophic dysplasia sulfate transporter (DTDST) gene mutations in HEK cells.</article-title>
                <source>Hum Mol Genet</source>
                <volume>13</volume>
                <fpage>2165</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">15294877</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.m_kitie.2004.278">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>M&#x000e4;kitie</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Czarny-Ratajczak</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wright</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogala</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freund</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jakkula</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ala-Kokko</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briggs</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>WG</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Clinical and radiographic findings in multiple epiphyseal dysplasia caused by MATN3 mutations: description of 12 patients.</article-title>
                <source>Am J Med Genet</source>
                <volume>125A</volume>
                <fpage>278</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">14994237</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.m_kitie.2003.187">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>M&#x000e4;kitie</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savarirayan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaf&#x000e9;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robertson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Susic</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cole</surname>
                    <given-names>WG</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Autosomal recessive multiple epiphyseal dysplasia with homozygosity for C653S in the DTDST gene: double-layer patella as a reliable sign.</article-title>
                <source>Am J Med Genet</source>
                <volume>122A</volume>
                <fpage>187</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">12966518</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.muragaki.1996.103">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Muragaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mariman</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Beersum</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perala</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Mourik</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warman</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olsen</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>BC</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>A mutation in the gene encoding the alpha 2 chain of the fibril-associated collagen IX, COL9A2, causes multiple epiphyseal dysplasia (EDM2).</article-title>
                <source>Nat Genet</source>
                <volume>12</volume>
                <fpage>103</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">8528240</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.paassilta.1999.1036">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Paassilta</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohiniva</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Annunen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaventure</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Merrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pai</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ala-Kokko</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>COL9A3: A third locus for multiple epiphyseal dysplasia.</article-title>
                <source>Am J Hum Genet</source>
                <volume>64</volume>
                <fpage>1036</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">10090888</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.rossi.1996.18456">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaventure</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delezoide</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cetta</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Undersulfation of proteoglycans synthesized by chondrocytes from a patient with achondrogenesis type 1B homozygous for an L483P substitution in the diastrophic dysplasia sulfate transporter.</article-title>
                <source>J Biol Chem</source>
                <volume>271</volume>
                <fpage>18456</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">8702490</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.rossi.1997.741">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaventure</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delezoide</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cetta</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Undersulfation of cartilage proteoglycans ex vivo and increased contribution of amino acid sulfur to sulfation in vitro in McAlister dysplasia/atelosteogenesis type 2.</article-title>
                <source>Eur J Biochem</source>
                <volume>248</volume>
                <fpage>741</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9342225</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.rossi.1998.361">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaitila</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcox</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimoin</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cetta</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: relationship to clinical severity and indications on the role of intracellular sulfate production.</article-title>
                <source>Matrix Biol</source>
                <volume>17</volume>
                <fpage>361</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9822202</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.rossi.2001.159">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene (SLC26A2): 22 novel mutations, mutation review, associated skeletal phenotypes, and diagnostic relevance.</article-title>
                <source>Hum Mutat</source>
                <volume>17</volume>
                <fpage>159</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">11241838</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.satoh.1998.12307">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Satoh</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Susaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shukunami</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iyama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Negoro</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiraki</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Functional analysis of diastrophic dysplasia sulfate transporter. Its involvement in growth regulation of chondrocytes mediated by sulfated proteoglycans.</article-title>
                <source>J Biol Chem</source>
                <volume>273</volume>
                <fpage>12307</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">9575183</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.supertifurga.1994.1137">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>A defect in the metabolic activation of sulfate in a patient with achondrogenesis type IB.</article-title>
                <source>Am J Hum Genet</source>
                <volume>55</volume>
                <fpage>1137</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">7977372</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.supertifurga.1996a.195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000e4;stbacka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Harten</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcox</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohn</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimoin</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lander</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gitzelmann</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1996a</year>
                <article-title>A family of chondrodysplasias caused by mutations in the diastrophic dysplasia sulfate transporter gene and associated with impaired sulfation of proteoglycans.</article-title>
                <source>Ann N Y Acad Sci</source>
                <volume>785</volume>
                <fpage>195</fpage>
                <lpage>201</lpage>
                <pub-id pub-id-type="pmid">8702127</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.supertifurga.1996b.100">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000e4;stbacka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcox</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohn</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Harten</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rossi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blau</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimoin</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lander</surname>
                    <given-names>ES</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gitzelmann</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1996b</year>
                <article-title>Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene.</article-title>
                <source>Nat Genet</source>
                <volume>12</volume>
                <fpage>100</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">8528239</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.supertifurga.1999.621">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riebel</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eich</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spranger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunze</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Recessively inherited multiple epiphyseal dysplasia with normal stature, club foot, and double layered patella caused by a DTDST mutation.</article-title>
                <source>J Med Genet</source>
                <volume>36</volume>
                <fpage>621</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">10465113</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.unger.2008.19">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Unger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaf&#x000e9;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Multiple epiphyseal dysplasia: clinical and radiographic features, differential diagnosis and molecular basis.</article-title>
                <source>Best Pract Res Clin Rheumatol</source>
                <volume>22</volume>
                <fpage>19</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">18328978</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.unger.2001.244">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Unger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hecht</surname>
                    <given-names>JT</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Pseudoachondroplasia and multiple epiphyseal dysplasia: new etiologic developments.</article-title>
                <source>Am J Med Genet</source>
                <volume>106</volume>
                <fpage>244</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">11891674</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.unger.2001.10">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Unger</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briggs</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holden</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ala-Kokko</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paassilta</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohiniva</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimoin</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachman</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohn</surname>
                    <given-names>DH</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Multiple epiphyseal dysplasia: radiographic abnormalities correlated with genotype.</article-title>
                <source>Pediatr Radiol</source>
                <volume>31</volume>
                <fpage>10</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11200990</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.warman.2011.943">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Warman</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krakow</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeMerrer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mundlos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishimura</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimoin</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robertson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savarirayan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sillence</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spranger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Unger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Nosology and classification of genetic skeletal disorders: 2010 revision.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2011</year>
                <volume>155A</volume>
                <fpage>943</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">21438135</pub-id>
              </element-citation>
            </ref>
            <ref id="edm.REF.zankl.2007.150">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zankl</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crettol</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elles</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spranger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zabel</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Unger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merrer</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wright</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonaf&#x000e9;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briggs</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Preselection of cases through expert clinical and radiographic review significantly increases mutation detection rate in multiple epiphyseal dysplasia.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>15</volume>
                <fpage>150</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">17133256</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="edm.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="edm.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>23 January 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>18 March 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>27 December 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>20 July 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>29 August 2002 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>25 February 2002 (db) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="edm.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Double patella<xref ref-type="bibr" rid="edm.REF.ballhausen.2003.65">Ballhausen et al [2003]</xref>; reprinted with permission from the BMJ Publishing Group</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="edm-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
